Status:
RECRUITING
Effect of Ketamine on Intraoperative Motor Evoked Potentials
Lead Sponsor:
University of California, San Francisco
Conditions:
Spine Fusion
Spine Tumor
Eligibility:
All Genders
18-100 years
Phase:
PHASE3
Brief Summary
The goal of this clinical trial is to learn about the effect of ketamine on intraoperative motor evoked potentials in adult patients undergoing thoracolumbar spinal fusions. Participants will undergo ...
Detailed Description
Spinal surgeries continue to increase in frequency and complexity. An important safety protocol is the use of intraoperative motor evoked potentials (MEP) to monitor the integrity and function of the ...
Eligibility Criteria
Inclusion
- Adult patients (\>18 years of age) undergoing posterior spinal fusions.
Exclusion
- Sensitivity or allergy to ketamine.
- Schizophrenia or other psychotic conditions
- Uncontrolled hypertension with systolic blood pressure greater than 180 mmHg
- Myocardial Infarction
- Large vascular aneurysms
- Patients on ketamine as outpatient therapy.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06140927
Start Date
December 1 2023
End Date
December 1 2026
Last Update
May 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143